Search Count: 20
 |
Crystal Structure Of Hiv Protease Complexed With (S)-N-(3-Fluoro-2-(2-(1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKD |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CL, CKD
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKM |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CL, CKM
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CL, CKS
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,5S)-5-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKV |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CL, CKV
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6S)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKY |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CL, CKY
 |
Crystal Structure Of Hiv Protease Complexed With N-(2-(2-((6R,9S)-2,2-Dioxido-2-Thia-1,7-Diazabicyclo[4.3.1]Decan-9-Yl)Ethyl)-3-Fluorophenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CN4, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-01-03
Ligands: CN4, CL
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-Benzhydryl-2-(3-Morpholin-4-Ium-2-Ylpropylamino)-2-Oxo-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: 6EH, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-05-18
Ligands: 6EH, CL
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-[[2-[(3S)-3-[(4-Aminophenyl)Methylamino]-4-Hydroxy-Butyl]Phenyl]Carbamoyl]-2,2-Diphenyl-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: CL, 6EG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-05-18
Ligands: CL, 6EG
 |
Crystal Structure Of Hiv Protease Complexed With Methyl N-[(1S)-1-Benzhydryl-2-[2-[2-[(2R,5S)-5-(Benzylcarbamoyloxymethyl)Morpholin-2-Yl]Ethyl]Anilino]-2-Oxo-Ethyl]Carbamate
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: CL, 6EF |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-05-18
Ligands: CL, 6EF
 |
Crystal Structure Of Hiv Protease Complexed With [(1S)-1-[(S)-(4-Chlorophenyl)-(3,5-Difluorophenyl)Methyl]-2-[[5-Fluoro-4-[2-[(2R,5S)-5-(2,2,2-Trifluoroethylcarbamoyloxymethyl)Morpholin-4-Ium-2-Yl]Ethyl]Pyridin-1-Ium-3-Yl]Amino]-2-Oxo-Ethyl]Ammonium
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2016-05-18 Classification: HYDROLASE/INHIBITOR Ligands: ACT, 6EE, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-05-18
Ligands: ACT, 6EE, CL
 |
Hiv-1 Reverse Transcriptase With Inhibitor
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2010-06-09 Classification: TRANSFERASE/HYDROLASE Ligands: MN, LP7, NVP |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2010-06-09
Ligands: MN, LP7, NVP
 |
Hiv-1 Reverse Transcriptase With Inhibitor
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2010-06-09 Classification: TRANSFERASE/HYDROLASE Ligands: LP8, MN, NVP |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2010-06-09
Ligands: LP8, MN, NVP
 |
Hiv-1 Reverse Transcriptase With Inhibitor
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2010-06-09 Classification: TRANSFERASE/HYDROLASE Ligands: LP9, MN |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2010-06-09
Ligands: LP9, MN
 |
P15 Hiv Rnaseh Domain With Inhibitor Mk3
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2010-06-09 Classification: VIRAL PROTEIN Ligands: MN, LP9 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2010-06-09
Ligands: MN, LP9
 |
Thrombin In Complex With An Oxazolopyridine Inhibitor 21
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2005-09-27 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 382 |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2005-09-27
Ligands: 382
 |
Thrombin In Complex With An Oxazolopyridine Inhibitor 2
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2005-09-27 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 501 |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2005-09-27
Ligands: 501
 |
Thrombin In Complex With An Azafluorenyl Inhibitor 23B
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2005-06-07 Classification: BLOOD CLOTTING,HYDROLASE/INHIBITOR Ligands: 062 |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2005-06-07
Ligands: 062
 |
Crystal Structue Of Thrombin In Complex With A Potent P1 Heterocycle-Aryl Based Inhibitor
Organism: Homo sapiens, Hirudo medicinalis
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2004-08-03 Classification: BLOOD CLOTTING,HYDROLASE/INHIBITOR Ligands: 170 |
Organism: Homo sapiens, Hirudo medicinalis
Method: X-RAY DIFFRACTION
Release Date: 2004-08-03
Ligands: 170
 |
Crystal Structure Of Thrombin In Complex With L-378,622
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2004-04-06 Classification: BLOOD CLOTTING,HYDROLASE/INHIBITOR Ligands: CDA |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2004-04-06
Ligands: CDA
 |
Thrombin-Hirugen_L-378,650
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2004-04-06 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CDB |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2004-04-06
Ligands: CDB